Viewing Study NCT00503295


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-01-24 @ 6:46 AM
Study NCT ID: NCT00503295
Status: COMPLETED
Last Update Posted: 2014-10-02
First Post: 2007-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
Sponsor: Oncolytics Biotech
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteosarcoma View
None Ewing Sarcoma Family Tumors View
None Malignant Fibrous Histiocytoma View
None Sarcoma, Synovial View
None Fibrosarcoma View
None Leiomyosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None reovirus View
None oncolytic virus View
None sarcoma View
None REOLYSIN View
None Oncolytics Biotech View